This content is machine translated Immunotherapy A narrow ridge With the rapid development of new, highly efficient anticancer drugs such as checkpoint inhibitors, an expanded spectrum of side effects of oncological therapies inevitably arises. The increasing use of immunotherapy…
View Post 2 min This content is machine translated Hypertrophic cardiomyopathies (HCM) Recognize rare causes This training course is all about differential diagnosis and therapy of hypertrophic cardiomyopathies (HCM). First, the previously known etiologies and their respective frequencies are highlighted. The very large group of…
View Post 2 min This content is machine translated Schwartz-Bartter syndrome Effectively balancing electrolyte imbalances: focus on osmoregulation Nausea, vomiting, headaches and muscle cramps may also result from water retention. In Schwarzt-Bartter syndrome, this is triggered by ADH accumulation. The cause is usually small cell lung cancer, but…
View Post 3 min This content is machine translated Cancer medicine of the future Car-T cell therapy and its application in practice CAR-T cell technology is considered the latest achievement in cancer medicine. The first approvals in Europe took place in mid-2018 – Switzerland followed at the end of 2018. Currently, the…
View Post 2 min This content is machine translated Multiple Myeloma Challenge accepted: Breaking boundaries in therapy Multiple myeloma is rare, but is one of the most common tumors of bone and bone marrow. Annually, there are about six to eight new cases per 100,000 inhabitants. Almost…
View Post 4 min This content is machine translated Dermatomyositis Auto-antibodies are diagnostically and prognostically significant In addition to history, clinical examination and imaging, the determination of antibodies is an important method for the diagnosis of dermatomyositis as well as a prognostic clue. Several specific antibodies…
View Post 5 min This content is machine translated Non-resectable BRAF-mutated melanoma Update COLUMBUS study: BRAF/MEK inhibition has long-lasting effect For almost two years, an effective therapeutic option has been available for patients with non-resectable or metastatic BRAFV600-mutated melanoma with the combination of encorafenib plus binimetinib. An analysis of the…
View Post 11 min This content is machine translated Sideropenia Iron deficiency in the oncological patient Worldwide, iron deficiency is the most common deficiency disease. In Europe, the prevalence is 5-10% and is one of the most common causes of anemia, accounting for about 50%. An…
View Post 4 min This content is machine translated Non-resectable melanoma New triple therapy improves progression-free survival Both protein kinase inhibitors and ipilimumab/nivolumab combined have better efficacy than their respective monotherapies in patients with non-resectable melanoma. This has been known for some time. An interesting new approach…
View Post 2 min This content is machine translated Multiple Myeloma Focus on symptom control – treatment options at a glance One of the most important decisions that must be made at the onset of symptomatic myeloma is that of adequate therapy. While not yet curable, a number of good options…
View Post 3 min This content is machine translated From symptom to diagnosis Mammary tumors of the male Malignancies of the male breast are very rare. In case of a suspected diagnosis, a careful clarification of clinical symptoms and anamnestic data is very important. Information sharing with the…
